{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T19:12:38Z","timestamp":1794251558040,"version":"4.9.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,6,29]],"date-time":"2018-06-29T00:00:00Z","timestamp":1530230400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,6,29]],"date-time":"2018-06-29T00:00:00Z","timestamp":1530230400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Huntington\u2019s disease (HD) is a progressive neurodegenerative disorder primarily affecting the basal ganglia and is caused by expanded CAG repeats in the huntingtin gene. Except for CAG sizing, mitochondrial and nuclear DNA (mtDNA and nDNA) parameters have not yet proven to be representative biomarkers for disease and future therapy. Here, we identified a general suppression of genes associated with aerobic metabolism in peripheral blood mononuclear cells (PBMCs) from HD patients compared to controls. In HD, the complex II subunit SDHB was lowered although not sufficiently to affect complex II activity. Nevertheless, we found decreased level of factors associated with mitochondrial biogenesis and an associated dampening of the mitochondrial DNA damage frequency in HD, implying an early defect in mitochondrial activity. In contrast to mtDNA, nDNA from HD patients was four-fold more modified than controls and demonstrated that nDNA integrity is severely reduced in HD. Interestingly, the level of nDNA damage correlated inversely with the total functional capacity (TFC) score; an established functional score of HD. Our data show that PBMCs are a promising source to monitor HD progression and highlights nDNA damage and diverging mitochondrial and nuclear genome responses representing early cellular impairments in HD.<\/jats:p>","DOI":"10.1038\/s41598-018-27985-y","type":"journal-article","created":{"date-parts":[[2018,6,25]],"date-time":"2018-06-25T09:31:47Z","timestamp":1529919107000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":57,"title":["Increased nuclear DNA damage precedes mitochondrial dysfunction in peripheral blood mononuclear cells from Huntington\u2019s disease patients"],"prefix":"10.1038","volume":"8","author":[{"given":"Georgina","family":"Askeland","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaneta","family":"Dosoudilova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Rodinova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiri","family":"Klempir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irena","family":"Liskova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Ku\u015bnierczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magnar","family":"Bj\u00f8r\u00e5s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaute","family":"Nesse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arne","family":"Klungland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hana","family":"Hansikova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3948-5183","authenticated-orcid":false,"given":"Lars","family":"Eide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,29]]},"reference":[{"key":"27985_CR1","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1021\/acs.biochem.6b00936","volume":"56","author":"A Adegbuyiro","year":"2017","unstructured":"Adegbuyiro, A., Sedighi, F., Pilkington, A. W. T., Groover, S. & Legleiter, J. Proteins Containing Expanded Polyglutamine Tracts and Neurodegenerative Disease. Biochemistry 56, 1199\u20131217, https:\/\/doi.org\/10.1021\/acs.biochem.6b00936 (2017).","journal-title":"Biochemistry"},{"key":"27985_CR2","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1126\/science.7618107","volume":"269","author":"MP Duyao","year":"1995","unstructured":"Duyao, M. P. et al. Inactivation of the mouse Huntington\u2019s disease gene homolog Hdh. Science 269, 407\u2013410 (1995).","journal-title":"Science"},{"key":"27985_CR3","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/0092-8674(95)90542-1","volume":"81","author":"J Nasir","year":"1995","unstructured":"Nasir, J. et al. Targeted disruption of the Huntington\u2019s disease gene results in embryonic lethality and behavioral and morphological changes in heterozygotes. Cell 81, 811\u2013823 (1995).","journal-title":"Cell"},{"key":"27985_CR4","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/ng1095-155","volume":"11","author":"S Zeitlin","year":"1995","unstructured":"Zeitlin, S., Liu, J. P., Chapman, D. L., Papaioannou, V. E. & Efstratiadis, A. Increased apoptosis and early embryonic lethality in mice nullizygous for the Huntington\u2019s disease gene homologue. Nat Genet 11, 155\u2013163, https:\/\/doi.org\/10.1038\/ng1095-155 (1995).","journal-title":"Nat Genet"},{"key":"27985_CR5","doi-asserted-by":"publisher","unstructured":"Unified Huntington\u2019s Disease Rating Scale: reliability and consistency. Huntington Study Group. Mov Disord 11, 136\u2013142, https:\/\/doi.org\/10.1002\/mds.870110204 (1996).","DOI":"10.1002\/mds.870110204"},{"key":"27985_CR6","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1038\/ejhg.2012.200","volume":"21","author":"M Losekoot","year":"2013","unstructured":"Losekoot, M. et al. EMQN\/CMGS best practice guidelines for the molecular genetic testing of Huntington disease. Eur J Hum Genet 21, 480\u2013486, https:\/\/doi.org\/10.1038\/ejhg.2012.200 (2013).","journal-title":"Eur J Hum Genet"},{"key":"27985_CR7","doi-asserted-by":"crossref","unstructured":"Aylward, E. H. et al. Rate of caudate atrophy in presymptomatic and symptomatic stages of Huntington\u2019s disease. Mov Disord 15, 552\u2013560, https:\/\/doi.org\/10.1002\/1531-8257(200005)15:3<552::AID-MDS1020>3.0.CO;2-P (2000).","DOI":"10.1002\/1531-8257(200005)15:3<552::AID-MDS1020>3.0.CO;2-P"},{"key":"27985_CR8","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1136\/jnnp.2007.128728","volume":"79","author":"JS Paulsen","year":"2008","unstructured":"Paulsen, J. S. et al. Detection of Huntington\u2019s disease decades before diagnosis: the Predict-HD study. J Neurol Neurosurg Psychiatry 79, 874\u2013880, https:\/\/doi.org\/10.1136\/jnnp.2007.128728 (2008).","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"27985_CR9","first-page":"217","volume":"21","author":"J Klempir","year":"2006","unstructured":"Klempir, J., Klempirova, O., Spackova, N., Zidovska, J. & Roth, J. Unified Huntington\u2019s disease rating scale: clinical practice and a critical approach. Funct Neurol 21, 217\u2013221 (2006).","journal-title":"Funct Neurol"},{"key":"27985_CR10","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/j.1399-0004.1985.tb00185.x","volume":"27","author":"LA Farrer","year":"1985","unstructured":"Farrer, L. A. Diabetes mellitus in Huntington disease. Clin Genet 27, 62\u201367 (1985).","journal-title":"Clin Genet"},{"key":"27985_CR11","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1007\/s00415-008-0964-x","volume":"255","author":"ME Busse","year":"2008","unstructured":"Busse, M. E., Hughes, G., Wiles, C. M. & Rosser, A. E. Use of hand-held dynamometry in the evaluation of lower limb muscle strength in people with Huntington\u2019s disease. J Neurol 255, 1534\u20131540, https:\/\/doi.org\/10.1007\/s00415-008-0964-x (2008).","journal-title":"J Neurol"},{"key":"27985_CR12","doi-asserted-by":"publisher","first-page":"11023","DOI":"10.1073\/pnas.0504921102","volume":"102","author":"F Borovecki","year":"2005","unstructured":"Borovecki, F. et al. Genome-wide expression profiling of human blood reveals biomarkers for Huntington\u2019s disease. Proc Natl Acad Sci USA 102, 11023\u201311028, https:\/\/doi.org\/10.1073\/pnas.0504921102 (2005).","journal-title":"Proc Natl Acad Sci USA"},{"key":"27985_CR13","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.nbd.2006.09.016","volume":"25","author":"MJ Mihm","year":"2007","unstructured":"Mihm, M. J. et al. Cardiac dysfunction in the R6\/2 mouse model of Huntington\u2019s disease. Neurobiol Dis 25, 297\u2013308, https:\/\/doi.org\/10.1016\/j.nbd.2006.09.016 (2007).","journal-title":"Neurobiol Dis"},{"key":"27985_CR14","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1038\/13518","volume":"5","author":"A Sawa","year":"1999","unstructured":"Sawa, A. et al. Increased apoptosis of Huntington disease lymphoblasts associated with repeat length-dependent mitochondrial depolarization. Nat Med 5, 1194\u20131198, https:\/\/doi.org\/10.1038\/13518 (1999).","journal-title":"Nat Med"},{"key":"27985_CR15","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.mad.2005.09.010","volume":"127","author":"F Squitieri","year":"2006","unstructured":"Squitieri, F. et al. Severe ultrastructural mitochondrial changes in lymphoblasts homozygous for Huntington disease mutation. Mech Ageing Dev 127, 217\u2013220, https:\/\/doi.org\/10.1016\/j.mad.2005.09.010 (2006).","journal-title":"Mech Ageing Dev"},{"key":"27985_CR16","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.bbrc.2008.07.009","volume":"374","author":"S Almeida","year":"2008","unstructured":"Almeida, S., Sarmento-Ribeiro, A. B., Januario, C., Rego, A. C. & Oliveira, C. R. Evidence of apoptosis and mitochondrial abnormalities in peripheral blood cells of Huntington\u2019s disease patients. Biochem Biophys Res Commun 374, 599\u2013603, https:\/\/doi.org\/10.1016\/j.bbrc.2008.07.009 (2008).","journal-title":"Biochem Biophys Res Commun"},{"key":"27985_CR17","first-page":"161","volume":"5","author":"X Liu","year":"1992","unstructured":"Liu, X., Luo, X. & Hu, W. Studies on the epidemiology and etiology of moldy sugarcane poisoning in China. Biomed Environ Sci 5, 161\u2013177 (1992).","journal-title":"Biomed Environ Sci"},{"key":"27985_CR18","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1093\/hmg\/10.2.137","volume":"10","author":"CH Lin","year":"2001","unstructured":"Lin, C. H. et al. Neurological abnormalities in a knock-in mouse model of Huntington\u2019s disease. Hum Mol Genet 10, 137\u2013144 (2001).","journal-title":"Hum Mol Genet"},{"key":"27985_CR19","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.cmet.2006.10.004","volume":"4","author":"P Weydt","year":"2006","unstructured":"Weydt, P. et al. Thermoregulatory and metabolic defects in Huntington\u2019s disease transgenic mice implicate PGC-1alpha in Huntington\u2019s disease neurodegeneration. Cell Metab 4, 349\u2013362, https:\/\/doi.org\/10.1016\/j.cmet.2006.10.004 (2006).","journal-title":"Cell Metab"},{"key":"27985_CR20","doi-asserted-by":"publisher","first-page":"3869","DOI":"10.1093\/hmg\/ddt242","volume":"22","author":"M Damiano","year":"2013","unstructured":"Damiano, M. et al. A role of mitochondrial complex II defects in genetic models of Huntington\u2019s disease expressing N-terminal fragments of mutant huntingtin. Hum Mol Genet 22, 3869\u20133882, https:\/\/doi.org\/10.1093\/hmg\/ddt242 (2013).","journal-title":"Hum Mol Genet"},{"key":"27985_CR21","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/nn884","volume":"5","author":"AV Panov","year":"2002","unstructured":"Panov, A. V. et al. Early mitochondrial calcium defects in Huntington\u2019s disease are a direct effect of polyglutamines. Nat Neurosci 5, 731\u2013736, https:\/\/doi.org\/10.1038\/nn884 (2002).","journal-title":"Nat Neurosci"},{"key":"27985_CR22","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/nature05778","volume":"447","author":"IV Kovtun","year":"2007","unstructured":"Kovtun, I. V. et al. OGG1 initiates age-dependent CAG trinucleotide expansion in somatic cells. Nature 447, 447\u2013452, https:\/\/doi.org\/10.1038\/nature05778 (2007).","journal-title":"Nature"},{"key":"27985_CR23","doi-asserted-by":"publisher","first-page":"4939","DOI":"10.1093\/hmg\/dds337","volume":"21","author":"L Mollersen","year":"2012","unstructured":"Mollersen, L. et al. Neil1 is a genetic modifier of somatic and germline CAG trinucleotide repeat instability in R6\/1 mice. Hum Mol Genet 21, 4939\u20134947, https:\/\/doi.org\/10.1093\/hmg\/dds337 (2012).","journal-title":"Hum Mol Genet"},{"key":"27985_CR24","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/70598","volume":"23","author":"K Manley","year":"1999","unstructured":"Manley, K., Shirley, T. L., Flaherty, L. & Messer, A. Msh2 deficiency prevents in vivo somatic instability of the CAG repeat in Huntington disease transgenic mice. Nat Genet 23, 471\u2013473, https:\/\/doi.org\/10.1038\/70598 (1999).","journal-title":"Nat Genet"},{"key":"27985_CR25","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1093\/hmg\/ddg056","volume":"12","author":"VC Wheeler","year":"2003","unstructured":"Wheeler, V. C. et al. Mismatch repair gene Msh2 modifies the timing of early disease in Hdh(Q111) striatum. Hum Mol Genet 12, 273\u2013281 (2003).","journal-title":"Hum Mol Genet"},{"key":"27985_CR26","doi-asserted-by":"publisher","first-page":"e1005267","DOI":"10.1371\/journal.pgen.1005267","volume":"11","author":"H Budworth","year":"2015","unstructured":"Budworth, H. et al. Suppression of Somatic Expansion Delays the Onset of Pathophysiology in a Mouse Model of Huntington\u2019s Disease. PLoS Genet 11, e1005267, https:\/\/doi.org\/10.1371\/journal.pgen.1005267 (2015).","journal-title":"PLoS Genet"},{"key":"27985_CR27","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1002\/stem.542","volume":"28","author":"W Wang","year":"2010","unstructured":"Wang, W. et al. Mitochondrial DNA integrity is essential for mitochondrial maturation during differentiation of neural stem cells. Stem Cells 28, 2195\u20132204, https:\/\/doi.org\/10.1002\/stem.542 (2010).","journal-title":"Stem Cells"},{"key":"27985_CR28","doi-asserted-by":"publisher","unstructured":"Pawar, T., Bjoras, M., Klungland, A. & Eide, L. Metabolism and DNA repair shape a specific modification pattern in mitochondrial DNA. Mitochondrion, https:\/\/doi.org\/10.1016\/j.mito.2017.09.002 (2017).","DOI":"10.1016\/j.mito.2017.09.002"},{"key":"27985_CR29","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.neuron.2005.06.005","volume":"47","author":"BI Bae","year":"2005","unstructured":"Bae, B. I. et al. p53 mediates cellular dysfunction and behavioral abnormalities in Huntington\u2019s disease. Neuron 47, 29\u201341, https:\/\/doi.org\/10.1016\/j.neuron.2005.06.005 (2005).","journal-title":"Neuron"},{"key":"27985_CR30","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/978-1-4939-3040-1_3","volume":"1351","author":"W Wang","year":"2016","unstructured":"Wang, W., Scheffler, K., Esbensen, Y. & Eide, L. Quantification of DNA Damage by Real-Time qPCR. Methods Mol Biol 1351, 27\u201332, https:\/\/doi.org\/10.1007\/978-1-4939-3040-1_3 (2016).","journal-title":"Methods Mol Biol"},{"key":"27985_CR31","doi-asserted-by":"publisher","first-page":"2655","DOI":"10.1084\/jem.20160776","volume":"213","author":"MH Disatnik","year":"2016","unstructured":"Disatnik, M. H. et al. Potential biomarkers to follow the progression and treatment response of Huntington\u2019s disease. J Exp Med 213, 2655\u20132669, https:\/\/doi.org\/10.1084\/jem.20160776 (2016).","journal-title":"J Exp Med"},{"key":"27985_CR32","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1002\/ana.410410514","volume":"41","author":"SE Browne","year":"1997","unstructured":"Browne, S. E. et al. Oxidative damage and metabolic dysfunction in Huntington\u2019s disease: selective vulnerability of the basal ganglia. Ann Neurol 41, 646\u2013653, https:\/\/doi.org\/10.1002\/ana.410410514 (1997).","journal-title":"Ann Neurol"},{"key":"27985_CR33","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.bbrc.2007.05.093","volume":"359","author":"CM Chen","year":"2007","unstructured":"Chen, C. M. et al. Increased oxidative damage and mitochondrial abnormalities in the peripheral blood of Huntington\u2019s disease patients. Biochem Biophys Res Commun 359, 335\u2013340, https:\/\/doi.org\/10.1016\/j.bbrc.2007.05.093 (2007).","journal-title":"Biochem Biophys Res Commun"},{"key":"27985_CR34","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1212\/WNL.0b013e318293e1a1","volume":"80","author":"B Borowsky","year":"2013","unstructured":"Borowsky, B. et al. 8OHdG is not a biomarker for Huntington disease state or progression. Neurology 80, 1934\u20131941, https:\/\/doi.org\/10.1212\/WNL.0b013e318293e1a1 (2013).","journal-title":"Neurology"},{"key":"27985_CR35","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s00421-010-1363-4","volume":"109","author":"AC Levada-Pires","year":"2010","unstructured":"Levada-Pires, A. C. et al. The effect of an adventure race on lymphocyte and neutrophil death. Eur J Appl Physiol 109, 447\u2013453, https:\/\/doi.org\/10.1007\/s00421-010-1363-4 (2010).","journal-title":"Eur J Appl Physiol"},{"key":"27985_CR36","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1007\/s11011-017-0026-0","volume":"32","author":"P Jedrak","year":"2017","unstructured":"Jedrak, P. et al. Mitochondrial DNA levels in Huntington disease leukocytes and dermal fibroblasts. Metab Brain Dis 32, 1237\u20131247, https:\/\/doi.org\/10.1007\/s11011-017-0026-0 (2017).","journal-title":"Metab Brain Dis"},{"key":"27985_CR37","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/j.cell.2006.11.013","volume":"127","author":"M Lagouge","year":"2006","unstructured":"Lagouge, M. et al. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell 127, 1109\u20131122, https:\/\/doi.org\/10.1016\/j.cell.2006.11.013 (2006).","journal-title":"Cell"},{"key":"27985_CR38","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1007\/s11745-015-4110-0","volume":"51","author":"EM Mejia","year":"2016","unstructured":"Mejia, E. M., Chau, S., Sparagna, G. C., Sipione, S. & Hatch, G. M. Reduced Mitochondrial Function in Human Huntington Disease Lymphoblasts is Not Due to Alterations in Cardiolipin Metabolism or Mitochondrial Supercomplex Assembly. Lipids 51, 561\u2013569, https:\/\/doi.org\/10.1007\/s11745-015-4110-0 (2016).","journal-title":"Lipids"},{"key":"27985_CR39","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1080\/24701394.2016.1180514","volume":"28","author":"T Pawar","year":"2017","unstructured":"Pawar, T. & Eide, L. Pitfalls in mitochondrial epigenetics. Mitochondrial DNA A DNA Mapp Seq Anal 28, 762\u2013768, https:\/\/doi.org\/10.1080\/24701394.2016.1180514 (2017).","journal-title":"Mitochondrial DNA A DNA Mapp Seq Anal"},{"key":"27985_CR40","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1080\/15384101.2015.1033595","volume":"14","author":"T Ratovitski","year":"2015","unstructured":"Ratovitski, T., Arbez, N., Stewart, J. C., Chighladze, E. & Ross, C. A. PRMT5- mediated symmetric arginine dimethylation is attenuated by mutant huntingtin and is impaired in Huntington\u2019s disease (HD). Cell Cycle 14, 1716\u20131729, https:\/\/doi.org\/10.1080\/15384101.2015.1033595 (2015).","journal-title":"Cell Cycle"},{"key":"27985_CR41","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.dnarep.2017.11.008","volume":"61","author":"K Scheffler","year":"2018","unstructured":"Scheffler, K. et al. 8-oxoguanine DNA glycosylase (Ogg1) controls hepatic gluconeogenesis. DNA Repair (Amst) 61, 56\u201362, https:\/\/doi.org\/10.1016\/j.dnarep.2017.11.008 (2018).","journal-title":"DNA Repair (Amst)"},{"key":"27985_CR42","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1073\/pnas.0507444103","volume":"103","author":"V Vartanian","year":"2006","unstructured":"Vartanian, V. et al. The metabolic syndrome resulting from a knockout of the NEIL1 DNA glycosylase. Proc Natl Acad Sci USA 103, 1864\u20131869, https:\/\/doi.org\/10.1073\/pnas.0507444103 (2006).","journal-title":"Proc Natl Acad Sci USA"},{"key":"27985_CR43","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1096\/fj.201600845R","volume":"31","author":"A Prokesch","year":"2017","unstructured":"Prokesch, A. et al. Liver p53 is stabilized upon starvation and required for amino acid catabolism and gluconeogenesis. FASEB J 31, 732\u2013742, https:\/\/doi.org\/10.1096\/fj.201600845R (2017).","journal-title":"FASEB J"},{"key":"27985_CR44","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1089\/ars.2012.4845","volume":"19","author":"E Maranzana","year":"2013","unstructured":"Maranzana, E., Barbero, G., Falasca, A. I., Lenaz, G. & Genova, M. L. Mitochondrial respiratory supercomplex association limits production of reactive oxygen species from complex I. Antioxid Redox Signal 19, 1469\u20131480, https:\/\/doi.org\/10.1089\/ars.2012.4845 (2013).","journal-title":"Antioxid Redox Signal"},{"key":"27985_CR45","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.dnarep.2014.03.003","volume":"18","author":"JM Strand","year":"2014","unstructured":"Strand, J. M., Scheffler, K., Bjoras, M. & Eide, L. The distribution of DNA damage is defined by region-specific susceptibility to DNA damage formation rather than repair differences. DNA Repair (Amst) 18, 44\u201351, https:\/\/doi.org\/10.1016\/j.dnarep.2014.03.003 (2014).","journal-title":"DNA Repair (Amst)"},{"key":"27985_CR46","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1002\/ana.410390317","volume":"39","author":"M Gu","year":"1996","unstructured":"Gu, M. et al. Mitochondrial defect in Huntington\u2019s disease caudate nucleus. Ann Neurol 39, 385\u2013389, https:\/\/doi.org\/10.1002\/ana.410390317 (1996).","journal-title":"Ann Neurol"},{"key":"27985_CR47","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1002\/ana.410430321","volume":"43","author":"J Arenas","year":"1998","unstructured":"Arenas, J. et al. Complex I defect in muscle from patients with Huntington\u2019s disease. Ann Neurol 43, 397\u2013400, https:\/\/doi.org\/10.1002\/ana.410430321 (1998).","journal-title":"Ann Neurol"},{"key":"27985_CR48","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1002\/1531-8249(200001)47:1<80::AID-ANA13>3.0.CO;2-K","volume":"47","author":"SJ Tabrizi","year":"2000","unstructured":"Tabrizi, S. J. et al. Mitochondrial dysfunction and free radical damage in the Huntington R6\/2 transgenic mouse. Ann Neurol 47, 80\u201386 (2000).","journal-title":"Ann Neurol"},{"key":"27985_CR49","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/j.mito.2011.08.008","volume":"11","author":"M Kaarbo","year":"2011","unstructured":"Kaarbo, M. et al. Human cytomegalovirus infection increases mitochondrial biogenesis. Mitochondrion 11, 935\u2013945, https:\/\/doi.org\/10.1016\/j.mito.2011.08.008 (2011).","journal-title":"Mitochondrion"},{"key":"27985_CR50","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1093\/hmg\/ddx041","volume":"26","author":"S Sharma","year":"2017","unstructured":"Sharma, S., Wang, J., Cortes Gomez, E., Taggart, R. T. & Baysal, B. E. Mitochondrial complex II regulates a distinct oxygen sensing mechanism in monocytes. Hum Mol Genet 26, 1328\u20131339, https:\/\/doi.org\/10.1093\/hmg\/ddx041 (2017).","journal-title":"Hum Mol Genet"},{"key":"27985_CR51","doi-asserted-by":"publisher","first-page":"e0189891","DOI":"10.1371\/journal.pone.0189891","volume":"12","author":"DJ Hensman Moss","year":"2017","unstructured":"Hensman Moss, D. J. et al. Quantification of huntingtin protein species in Huntington\u2019s disease patient leukocytes using optimised electrochemiluminescence immunoassays. PLoS One 12, e0189891, https:\/\/doi.org\/10.1371\/journal.pone.0189891 (2017).","journal-title":"PLoS One"},{"key":"27985_CR52","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.bbi.2014.09.011","volume":"44","author":"KH Chang","year":"2015","unstructured":"Chang, K. H., Wu, Y. R., Chen, Y. C. & Chen, C. M. Plasma inflammatory biomarkers for Huntington\u2019s disease patients and mouse model. Brain Behav Immun 44, 121\u2013127, https:\/\/doi.org\/10.1016\/j.bbi.2014.09.011 (2015).","journal-title":"Brain Behav Immun"},{"key":"27985_CR53","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","volume":"72","author":"MM Bradford","year":"1976","unstructured":"Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72, 248\u2013254 (1976).","journal-title":"Anal Biochem"},{"key":"27985_CR54","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/0003-2697(87)90587-2","volume":"166","author":"H Schagger","year":"1987","unstructured":"Schagger, H. & von Jagow, G. Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal Biochem 166, 368\u2013379 (1987).","journal-title":"Anal Biochem"},{"key":"27985_CR55","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","volume":"193","author":"OH Lowry","year":"1951","unstructured":"Lowry, O. H., Rosebrough, N. J., Farr, A. L. & Randall, R. J. Protein measurement with the Folin phenol reagent. J Biol Chem 193, 265\u2013275 (1951).","journal-title":"J Biol Chem"},{"key":"27985_CR56","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.earlhumdev.2006.07.008","volume":"84","author":"T Honzik","year":"2008","unstructured":"Honzik, T. et al. Activities of respiratory chain complexes and pyruvate dehydrogenase in isolated muscle mitochondria in premature neonates. Early Hum Dev 84, 269\u2013276, https:\/\/doi.org\/10.1016\/j.earlhumdev.2006.07.008 (2008).","journal-title":"Early Hum Dev"},{"key":"27985_CR57","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1042\/BJ20091714","volume":"428","author":"D Fornuskova","year":"2010","unstructured":"Fornuskova, D. et al. Novel insights into the assembly and function of human nuclear-encoded cytochrome c oxidase subunits 4, 5a, 6a, 7a and 7b. Biochem J 428, 363\u2013374, https:\/\/doi.org\/10.1042\/BJ20091714 (2010).","journal-title":"Biochem J"},{"key":"27985_CR58","first-page":"8","volume":"ume 13","author":"PA Srere","year":"1969","unstructured":"Srere, P. A. & John, M. L. Citrate synthase: [EC 4.1.3.7. Citrate oxaloacetate-lyase (CoA-acetylating)]. Methods in Enzymology ume 13, 8 (1969).","journal-title":"Methods in Enzymology"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-27985-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-27985-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-27985-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T06:45:08Z","timestamp":1671605108000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-27985-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,29]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["27985"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-27985-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,29]]},"assertion":[{"value":"8 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"9817"}}